195 related articles for article (PubMed ID: 36794643)
1. A hierarchical multilabel graph attention network method to predict the deterioration paths of chronic hepatitis B patients.
Wu ZE; Xu D; Hu PJ; Huang TS
J Am Med Inform Assoc; 2023 Apr; 30(5):846-858. PubMed ID: 36794643
[TBL] [Abstract][Full Text] [Related]
2. Predictive Analytics for Care and Management of Patients With Acute Diseases: Deep Learning-Based Method to Predict Crucial Complication Phenotypes.
Sheng JQ; Hu PJ; Liu X; Huang TS; Chen YH
J Med Internet Res; 2021 Feb; 23(2):e18372. PubMed ID: 33576744
[TBL] [Abstract][Full Text] [Related]
3. KAMPNet: multi-source medical knowledge augmented medication prediction network with multi-level graph contrastive learning.
An Y; Tang H; Jin B; Xu Y; Wei X
BMC Med Inform Decis Mak; 2023 Oct; 23(1):243. PubMed ID: 37904198
[TBL] [Abstract][Full Text] [Related]
4. A deep learning-based, unsupervised method to impute missing values in electronic health records for improved patient management.
Xu D; Hu PJ; Huang TS; Fang X; Hsu CC
J Biomed Inform; 2020 Nov; 111():103576. PubMed ID: 33010424
[TBL] [Abstract][Full Text] [Related]
5. Learning global dependencies and multi-semantics within heterogeneous graph for predicting disease-related lncRNAs.
Xuan P; Wang S; Cui H; Zhao Y; Zhang T; Wu P
Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 36088549
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic hepatitis B: case selection and duration of therapy.
Leung N
J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
[TBL] [Abstract][Full Text] [Related]
7. Predicting hepatocellular carcinoma recurrences: A data-driven multiclass classification method incorporating latent variables.
Xu D; Sheng JQ; Hu PJ; Huang TS; Lee WC
J Biomed Inform; 2019 Aug; 96():103237. PubMed ID: 31238108
[TBL] [Abstract][Full Text] [Related]
8. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
9. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
[TBL] [Abstract][Full Text] [Related]
10. A deep learning model with data integration of ultrasound contrast-enhanced micro-flow cines, B-mode images, and clinical parameters for diagnosing significant liver fibrosis in patients with chronic hepatitis B.
Liu Z; Li W; Zhu Z; Wen H; Li MD; Hou C; Shen H; Huang B; Luo Y; Wang W; Chen X
Eur Radiol; 2023 Aug; 33(8):5871-5881. PubMed ID: 36735040
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the therapeutic efficacy and factors influencing sequential combination of nucleos(t)ide analogues with pegylated interferon alpha for 48~96 weeks in the treatment of patients with chronic hepatitis B].
Jia R; Wang WX; Zhou ZP; Nie WM; Cheng YQ; Zhao J; Lian F; Luan JQ; Wang FS; Fu JL
Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1290-1296. PubMed ID: 38253073
[No Abstract] [Full Text] [Related]
12. Diagnosis of significant liver fibrosis in patients with chronic hepatitis B using a deep learning-based data integration network.
Liu Z; Wen H; Zhu Z; Li Q; Liu L; Li T; Xu W; Hou C; Huang B; Li Z; Dong C; Chen X
Hepatol Int; 2022 Jun; 16(3):526-536. PubMed ID: 35312969
[TBL] [Abstract][Full Text] [Related]
13. Real-world epidemiology, treatment patterns and disease burden of patients diagnosed with chronic hepatitis B in Taiwan.
Chien HT; Su TH; Huang H; Chiang CL; Lin FJ
Liver Int; 2023 Nov; 43(11):2404-2414. PubMed ID: 37615056
[TBL] [Abstract][Full Text] [Related]
14. Serum M2BPGi level is a novel predictive biomarker for the responses to pegylated interferon-α treatment in HBeAg-positive chronic hepatitis B patients.
Zhu MY; Chen PZ; Li J; Yu DM; Huang D; Zhu XJ; Han Y; Chen J; Huang W; Chen YY; Gong QM; Jiang JH; Zhang DH; Zhang Y; Zhang JM; Zhang XX
J Med Virol; 2018 Apr; 90(4):721-729. PubMed ID: 29247529
[TBL] [Abstract][Full Text] [Related]
15. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
Han Y; Tang Q; Zhu W; Zhang X; You L
J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
[TBL] [Abstract][Full Text] [Related]
16. A Deep Learning-Based Unsupervised Method to Impute Missing Values in Patient Records for Improved Management of Cardiovascular Patients.
Xu D; Sheng JQ; Hu PJ; Huang TS; Hsu CC
IEEE J Biomed Health Inform; 2021 Jun; 25(6):2260-2272. PubMed ID: 33095720
[TBL] [Abstract][Full Text] [Related]
17. Prediction of hepatic inflammation in chronic hepatitis B patients with a random forest-backward feature elimination algorithm.
Zhou JY; Song LW; Yuan R; Lu XP; Wang GQ
World J Gastroenterol; 2021 Jun; 27(21):2910-2920. PubMed ID: 34135561
[TBL] [Abstract][Full Text] [Related]
18. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.
Park HS; Choe WH; Han HS; Yu MH; Kim YJ; Jung SI; Kim JH; Kwon SY
World J Gastroenterol; 2019 Jul; 25(25):3256-3267. PubMed ID: 31333316
[TBL] [Abstract][Full Text] [Related]
19. Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal.
Wu Z; Dong X; Wang G; Zhao H;
J Viral Hepat; 2019 Feb; 26(2):287-296. PubMed ID: 30380162
[TBL] [Abstract][Full Text] [Related]
20. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
Zeng DW; Dong J; Jiang JJ; Zhu YY; Liu YR
World J Gastroenterol; 2016 Nov; 22(43):9586-9594. PubMed ID: 27920479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
